tiprankstipranks

Erick Lucera Insider Profile

4 Followers
Erick Lucera, CFO at Dyne Therapeutics, holds 119.77K shares in Dyne Therapeutics (Ticker: DYN), holds 43.61K shares in Beyond Air (Ticker: XAIR), holds ― shares in AVEO Pharma (Ticker: AVEO).
tipranks
Erick Lucera

Erick Lucera
Dyne Therapeutics (DYN)
CFO

Ranked #97,774 out of 108,575 Corporate Insiders

Profitable Transactions

0%
0 out of 3 Profitable Transactions

Average Return

-55.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4M
84.38%
9.64%
5.98%
0.00%
0.00% Others
A breakdown of Erick Lucera's holdings

Insider Roles

Dyne Therapeutics
(DYN)
CFO
Editas Medicine
(EDIT)
EVP & CFO
Beyond Air
(XAIR)
Director
Bone Biologics
(BBLG)
Director
+1 other positions
Roles that Erick Lucera holds in companies

Most Profitable Insider Trade

Stock:
Dyne Therapeutics
(DYN)
Rating:Informative Sell
Date:Jun 26, 2026 - Today
Return:-22.70%
The most profitable trade made by Erick Lucera

Erick Lucera's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Dyne Therapeutics
Aug 17, 2026
CFO
Uninformative Sell
47.23K
$3.21M
Beyond Air
Aug 15, 2024
Director
Informative Buy
15.31K
$227.20K
AVEO
AVEO Pharma
VLRXQ
Valeritas Holdings
Bone Biologics
Director
SAB Biotherapeutics
Director
Editas Medicine
Mar 05, 2025
EVP & CFO
Uninformative Sell
7.03K
$366.34K
List of latest transactions for each holding click on a transaction to see Erick Lucera's performance on stock

Erick Lucera insider profile FAQ

What is the percentage of profitable transactions made by Erick Lucera?
The percentage of profitable transactions made by Erick Lucera is 0%.
    What is the average return per transaction made by Erick Lucera?
    The average return per transaction made by Erick Lucera is -55.90%.
      What stocks does Erick Lucera hold?
      Erick Lucera holds: DYN, XAIR, AVEO, VLRXQ, BBLG, SABS, EDIT stocks.
        What was Erick Lucera’s latest transaction?
        Erick Lucera latest transaction was an Uninformative Sell of $47.23K.
          What was Erick Lucera's most profitable transaction?
          Erick Lucera’s most profitable transaction was an Informative Sell of DYN stock on June 26, 2026. The return on the trade was -22.70%.
            What is Erick Lucera's role in Dyne Therapeutics?
            Erick Lucera's role in Dyne Therapeutics is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.